Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Bassetti

Showing results (541-550 of 742) with videos related to

Pageof 75
Sort By:
Infectious Diseases and Therapy|March 3, 2025
Cefiderocol for the Treatment of Nosocomial Bloodstream Infections Caused by Stenotrophomonas maltophilia: A Case Series and Literature ReviewAntonio Vena, Laura Mezzogori, Nadia Castaldo, et al.
Journal of Fungi (Basel, Switzerland)|April 27, 2026
Targeted Screening to Predict <i>Magnusiomyces</i> Infections in Hematopoietic Cell Transplant Recipients: Evidence from an Outbreak SettingClaudia Bartalucci, Chiara Russo, Anna Maria Raiola, et al.
European Journal of Internal Medicine|August 7, 2016
MEDical wards Invasive Candidiasis ALgorithms (MEDICAL):Consensus proposal for managementLuigia Scudeller, Matteo Bassetti, Ercole Concia, et al.
Critical Care (London, England)|April 19, 2015
Pharmacokinetic variability and exposures of fluconazole, anidulafungin, and caspofungin in intensive care unit patients: Data from multinational Defining Antibiotic Levels in Intensive care unit (DALI) patients StudyMahipal G Sinnollareddy, Jason A Roberts, Jeffrey Lipman, et al.
Lancet (London, England)|November 28, 2022
Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trialGeorge R Thompson, Alex Soriano, Oliver A Cornely, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 17, 2014
DALI: defining antibiotic levels in intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients?Jason A Roberts, Sanjoy K Paul, Murat Akova, et al.
Annals of Medicine|November 27, 2023
Early diagnosis of candidemia with explainable machine learning on automatically extracted laboratory and microbiological data: results of the AUTO-CAND projectDaniele Roberto Giacobbe, Cristina Marelli, Sara Mora, et al.
Future Microbiology|April 13, 2021
Tuberculosis treatment outcomes in a rural area of Senegal: a decade of experience from 2010 to 2019 by StopTB ItaliaNiccolò Riccardi, Simone Villa, Andrea Giacomelli, et al.
Infectious Diseases and Therapy|September 4, 2024
Mycoplasma hominis as Cause of Extragenital Infection in Patients with Hypogammaglobulinemia: Report of 2 Cases and Literature ReviewChiara Russo, Malgorzata Mikulska, Emanuele Delfino, et al.
Intensive Care Medicine|March 27, 2019
ESICM/ESCMID task force on practical management of invasive candidiasis in critically ill patientsIgnacio Martin-Loeches, Massimo Antonelli, Manuel Cuenca-Estrella, et al.
Pageof 75

Showing results (541-550 of 742) with videos related to

Sort By:
Pageof 75
Infectious Diseases and Therapy|March 3, 2025
Cefiderocol for the Treatment of Nosocomial Bloodstream Infections Caused by Stenotrophomonas maltophilia: A Case Series and Literature ReviewAntonio Vena, Laura Mezzogori, Nadia Castaldo, et al.
Journal of Fungi (Basel, Switzerland)|April 27, 2026
Targeted Screening to Predict <i>Magnusiomyces</i> Infections in Hematopoietic Cell Transplant Recipients: Evidence from an Outbreak SettingClaudia Bartalucci, Chiara Russo, Anna Maria Raiola, et al.
European Journal of Internal Medicine|August 7, 2016
MEDical wards Invasive Candidiasis ALgorithms (MEDICAL):Consensus proposal for managementLuigia Scudeller, Matteo Bassetti, Ercole Concia, et al.
Critical Care (London, England)|April 19, 2015
Pharmacokinetic variability and exposures of fluconazole, anidulafungin, and caspofungin in intensive care unit patients: Data from multinational Defining Antibiotic Levels in Intensive care unit (DALI) patients StudyMahipal G Sinnollareddy, Jason A Roberts, Jeffrey Lipman, et al.
Lancet (London, England)|November 28, 2022
Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trialGeorge R Thompson, Alex Soriano, Oliver A Cornely, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 17, 2014
DALI: defining antibiotic levels in intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients?Jason A Roberts, Sanjoy K Paul, Murat Akova, et al.
Annals of Medicine|November 27, 2023
Early diagnosis of candidemia with explainable machine learning on automatically extracted laboratory and microbiological data: results of the AUTO-CAND projectDaniele Roberto Giacobbe, Cristina Marelli, Sara Mora, et al.
Future Microbiology|April 13, 2021
Tuberculosis treatment outcomes in a rural area of Senegal: a decade of experience from 2010 to 2019 by StopTB ItaliaNiccolò Riccardi, Simone Villa, Andrea Giacomelli, et al.
Infectious Diseases and Therapy|September 4, 2024
Mycoplasma hominis as Cause of Extragenital Infection in Patients with Hypogammaglobulinemia: Report of 2 Cases and Literature ReviewChiara Russo, Malgorzata Mikulska, Emanuele Delfino, et al.
Intensive Care Medicine|March 27, 2019
ESICM/ESCMID task force on practical management of invasive candidiasis in critically ill patientsIgnacio Martin-Loeches, Massimo Antonelli, Manuel Cuenca-Estrella, et al.
Pageof 75